Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial - Johnson, David W; Badve, Sunil V; Pascoe, Elaine M; Beller, Elaine; Cass, Alan; Clark, Carolyn; de Zoysa, Janak; Isbel, Nicole M; McTaggart, Steven; Morrish, Alicia T; Playford, E Geoffrey; Scaria, Anish; et al. (The Lancet infectious diseases, 2014)
Keywords: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Anti-Bacterial Agents - administration & dosage; Antibacterial agents; Antibiotics. Antiinfectious agents. Antiparasitic agents; Australia; Bacterial Infections - prevention & control; Biological and medical sciences; Carrier State - drug therapy; Child; Child, Preschool; Dialysis; Emergency and intensive care: renal failure. Dialysis management; Female; Honey; Humans; Indexing in process; Infectious Disease; Infectious diseases; Intensive care medicine; Male; Medical sciences; Middle Aged; Mupirocin - administration & dosage; New Zealand; Peritoneal Dialysis - adverse effects; Peritonitis - prevention & control; Pharmacology. Drug treatments; Prevention; Prophylaxis; Staphylococcus aureus; Time Factors; Treatment Outcome; New Zealand; Australia; Prevention; Extrarenal dialysis; Honey; Antibacterial agent; Peritoneal dialysis